Covalon Technologies Ltd. (CVE:COV – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Monday. The stock traded as high as C$4.40 and last traded at C$4.27, with a volume of 49201 shares traded. The stock had previously closed at C$4.24.
Covalon Technologies Stock Up 6.1%
The firm has a 50 day moving average of C$2.79 and a 200-day moving average of C$2.28. The company has a debt-to-equity ratio of 5.35, a current ratio of 8.56 and a quick ratio of 6.45. The stock has a market capitalization of C$124.28 million, a P/E ratio of 28.12 and a beta of 1.40.
About Covalon Technologies
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
See Also
- Five stocks we like better than Covalon Technologies
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
